Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
NCT01195389 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2011-07-08
Summary
The purpose of this study is to determine if low level magnetic fields can help to improve memory in patients diagnosed with Alzheimer's dementia.
Conditions
- Alzheimer's Dementia
Interventions
- DEVICE
-
Resonator
Treatment group vs. Placebo group
Sponsors & Collaborators
-
pico-tesla Magnetic Therapies, LLC
lead INDUSTRY
Principal Investigators
-
Amanda Smith, MD · University South Florida Health Byrd Alzheimer's Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2011-10-31
- Completion
- 2011-10-31
Countries
- United States
Study Locations
More Related Trials
-
Feasibility Study of Transcranial Ultrasound Stimulation on Alzheimer's Disease Patients
NCT03896698 ·Status: UNKNOWN ·Phase: NA
-
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
NCT00930059 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Subjects With Mild-to-Moderate Alzheimer's Dementia
NCT05834296 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease
NCT00988598 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of a Biophoton Therapy on Patients With Brain Disorders
NCT06147999 ·Status: RECRUITING ·Phase: NA
-
Deep Brain Stimulation for Treatment of Severe Alzheimer's Disease
NCT03115814 ·Status: UNKNOWN
-
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
NCT00551161 ·Status: COMPLETED ·Phase: PHASE4
-
Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
NCT00842673 ·Status: COMPLETED ·Phase: PHASE2
-
A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease
NCT05983575 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD
NCT04191486 ·Status: COMPLETED ·Phase: PHASE2
-
Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease
NCT04055376 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
NCT00200538 ·Status: COMPLETED ·Phase: PHASE2
-
Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
NCT02811653 ·Status: UNKNOWN ·Phase: NA
-
TNF-Alpha Inhibition for Treatment of Alzheimer's Disease
NCT00203359 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study Between Alzheimer's and Multi-infarct Dementia
NCT05781139 ·Status: RECRUITING
-
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
NCT00322153 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)
NCT00874939 ·Status: TERMINATED ·Phase: PHASE1
-
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
NCT00933608 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease
NCT01492374 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease
NCT03765762 ·Status: COMPLETED ·Phase: PHASE2
-
Neurostimulation for Cognitive Enhancement in Alzheimer's Disease
NCT04404153 ·Status: COMPLETED ·Phase: NA
-
Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
NCT05904132 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease
NCT06546995 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
NCT00857649 ·Status: TERMINATED ·Phase: PHASE3
-
Safety of a Strategy Combining Etanercept Administration With Repeated Contrast Ultrasound in Patients With Alzheimer's Disease
NCT06585384 ·Status: RECRUITING ·Phase: PHASE1